|
1
|
venBio Partners
San Francisco,
California
|
$144M
|
–
|
–
|
–
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$111M
|
+$17.8M
|
+1,880,874
|
+34%
|
|
|
3
|
Vivo Capital
Palo Alto,
California
|
$62.8M
|
–
|
–
|
–
|
|
|
4
|
Redmile Group
San Francisco,
California
|
$54.5M
|
+$22.5M
|
+2,375,975
|
+185%
|
|
|
5
|
Cormorant Asset Management
Boston,
Massachusetts
|
$46.8M
|
+$24M
|
+2,530,000
|
+413%
|
|
|
6
|
|
$46.1M
|
+$2.13M
|
+224,000
|
+8%
|
|
|
7
|
|
$33.3M
|
+$3.72M
|
+392,074
|
+21%
|
|
|
8
|
Vestal Point Capital
New York
|
$24.6M
|
+$15.7M
|
+1,655,000
|
New
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$22.4M
|
+$4.69M
|
+494,173
|
+49%
|
|
|
10
|
MPM BioImpact
Boston,
Massachusetts
|
$18.8M
|
+$12M
|
+1,264,759
|
New
|
|
|
11
|
Citadel Advisors
Miami,
Florida
|
$18.4M
|
+$7.66M
|
+807,890
|
+190%
|
|
|
12
|
Point72 Asset Management
Stamford,
Connecticut
|
$13.6M
|
+$8.67M
|
+913,700
|
New
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$8.71M
|
+$1.35M
|
+141,967
|
+32%
|
|
|
14
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$8.09M
|
+$5.15M
|
+543,243
|
New
|
|
|
15
|
State Street
Boston,
Massachusetts
|
$7.47M
|
+$1.06M
|
+112,137
|
+29%
|
|
|
16
|
|
$6.16M
|
+$762K
|
+80,310
|
+24%
|
|
|
17
|
|
$5.74M
|
+$3.65M
|
+385,232
|
New
|
|
|
18
|
Renaissance Technologies
New York
|
$4.03M
|
+$550K
|
+58,000
|
+27%
|
|
|
19
|
Northern Trust
Chicago,
Illinois
|
$3.63M
|
+$496K
|
+52,316
|
+27%
|
|
|
20
|
Charles Schwab
San Francisco,
California
|
$3.1M
|
+$640K
|
+67,430
|
+48%
|
|
|
21
|
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.93M
|
-$520K
|
-54,824
|
-22%
|
|
|
22
|
Adage Capital Partners
Boston,
Massachusetts
|
$2.38M
|
+$1.52M
|
+160,000
|
New
|
|
|
23
|
Dimensional Fund Advisors
Austin,
Texas
|
$2M
|
-$4.91K
|
-517
|
-0.4%
|
|
|
24
|
Los Angeles Capital Management
Los Angeles,
California
|
$1.84M
|
-$221K
|
-23,257
|
-16%
|
|
|
25
|
Nuveen
Charlotte,
North Carolina
|
$1.58M
|
+$173K
|
+18,241
|
+21%
|
|
